Novavax | NVAX - Ebitda





Ebitda Изменить Дата
Adma Biologics USD 55.44M 5.62M 2026-06
Agenus USD -10.11M 19.02M 2025-03
AstraZeneca USD 7.46B 2.3B 2026-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Cassava Sciences USD -11.73M 33.44M 2025-09
Geron USD -9.2M 13.03M 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
MannKind USD 2.47M 461K 2026-06
Merck USD 1.42B 2.97B 2026-06
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Moderna USD -687M 571M 2026-06
Novartis USD 5.36B 45M 2026-09
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.36B 350M 2026-09
Sanofi EUR 5.79B 2.1B 2026-09
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
TG Therapeutics USD 26.9M 1.21M 2026-06